Browse Category

NYSE:MFA News 11 January 2026

AGNC stock rises with mortgage REITs after Trump’s $200B MBS order — what to watch next week

AGNC stock rises with mortgage REITs after Trump’s $200B MBS order — what to watch next week

AGNC Investment Corp. closed Friday up about 2% after President Trump ordered $200 billion in mortgage bond purchases, sending housing-linked stocks higher. AGNC ended at $11.41. Traders await more details on the program and Tuesday’s U.S. CPI data. The move narrowed mortgage spreads and lifted agency MBS prices, but market reaction remains cautious.

Stock Market Today

NASA’s SPHEREx spots interstellar comet 3I/ATLAS flaring on its way out — and the chemistry surprised scientists

NASA’s SPHEREx spots interstellar comet 3I/ATLAS flaring on its way out — and the chemistry surprised scientists

7 February 2026
NASA’s SPHEREx telescope detected interstellar comet 3I/ATLAS sharply brightening in December 2025 as it left the solar system, with infrared data revealing a surge of gas and dust, including water vapor and organic molecules. The comet, only the third confirmed interstellar object, passed no closer than 1.8 astronomical units from Earth. China’s Tianwen-1 Mars orbiter also captured images of the comet.
AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop